Nida and the FDA published United States trends in non-prescribed use of Adderall and Ritalin: Population Assessment of Tobacco and Health (PATH) Study estimates 2013-2022, claiming that such use has declined.
Nida and the FDA published United States trends in non-prescribed use of Adderall and Ritalin: Population Assessment of Tobacco and Health (PATH) Study estimates 2013-2022, claiming that such use has declined.